Nanoengineers at the University of California San Diego have developed a computer-based method that could make it less labor-intensive to determine the crystal structures of various materials and molecules, including alloys, proteins and pharmaceuticals. The method uses a machine learning a ... more
Genes that helps prevent brain disease
Scientists know that faulty proteins can cause harmful deposits or "aggregates" in neurological disorders such as Alzheimer's and Parkinson's disease. Although the causes of these protein deposits remain a mystery, it is known that abnormal aggregates can result when cells fail to transmit proper genetic information to proteins. University of California San Diego Professor Susan Ackerman and her colleagues first highlighted this cause of brain disease more than 10 years ago. Now, probing deeper into this research, she and colleagues have identified a gene, Ankrd16, that prevents the protein aggregates they originally observed.
Usually, the information transfer from gene to protein is carefully controlled--biologically "proofread" and corrected--to avoid the production of improper proteins. As part of their recent investigations Ackerman, Paul Schimmel (Scripps Research Institute) My-Nuong Vo (Scripps Research Institute) and Markus Terrey (UC San Diego) identified that Ankrd16 rescued specific neurons--called Purkinje cells --that die when proofreading fails. Without normal levels of Ankrd16, these nerve cells, located in the cerebellum, incorrectly activate the amino acid serine, which is then improperly incorporated into proteins and causes protein aggregation.
"Simplified, you may think of Ankrd16 as acting like a sponge or a 'failsafe' that captures incorrectly activated serine and prevents this amino acid from being improperly incorporated into proteins, which is particularly helpful when the ability of nerve cells to proofread and correct mistakes declines," said Ackerman, the Stephen W. Kuffler Chair in Biology, who also holds positions in the UC San Diego School of Medicine and the Howard Hughes Medical Institute.
The levels of Ankrd16 are normally low in Purkinje cells, making these neurons vulnerable to proofreading defects. Elevating the level of Ankrd16 protects these cells from dying, while removing Ankrd16 from other neurons in mice with a proofreading deficiency caused widespread buildup of abnormal proteins and ultimately neuronal death.
The researchers describe Ankrd16 as "...a new layer of the machinery essential for preventing severe pathologies that arise from defects in proofreading."
The researchers note that only a few modifier genes of disease mutations such as Ankrd16 have been identified and a modifier-based mechanism for understanding the underlying pathology of neurodegenerative diseases may be a promising route to understand disease development.
- UC San Diego
- Purkinje cells
- protein aggregation
- protein aggregates
- Parkinson's disease
- neurological disorders
- neurodegenerative diseases
- nerve cells
- Alzheimer's disease
Researchers at University of California San Diego School of Medicine report that detection of "copy editing" by a stem cell enzyme called ADAR1, which is active in more than 20 tumor types, may provide a kind of molecular radar for early detection of malignancies and represent a new therape ... more
By stacking and connecting layers of stretchable circuits on top of one another, engineers have developed an approach to build soft, pliable "3D stretchable electronics" that can pack a lot of functions while staying thin and small in size. As a proof of concept, a team led by the Universit ... more
A team of mechanical engineers at the University of California San Diego has successfully used acoustic waves to move fluids through small channels at the nanoscale. The breakthrough is a first step toward the manufacturing of small, portable devices that could be used for drug discovery an ... more
- 1analytica 2020: World’s leading trade fair to be held virtually
- 2analytica 2020: The world’s leading trade fair extends its reach with analytica virtual
- 3Portable, point-of-care COVID-19 test could bypass the lab
- 4Researchers dramatically downsize technology for fingerprinting drugs and other chemicals
- 5Attacking tumours directly on identification
- 6Towards a cell-based interceptive medicine in Europe
- 7Giant nanomachine aids the immune system
- 8A tiny instrument to measure the faintest magnetic fields
- 9Leap forward in the fight against antibiotic resistance
- 10New device can measure toxic lead within minutes
- Blood-based test accurately identifies viral infection before symptoms develop
- Method to safely study COVID-19, other contagious diseases developed
- QIAGEN fully acquires NeuMoDx Molecular
- Bruker Announces Acquisition of Canopy Biosciences, LLC
- Portable, point-of-care COVID-19 test could bypass the lab